Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Genscript Biotech ( (HK:1548) ).
Legend Biotech Corporation, an associate of Genscript Biotech, reported approximately US$334 million in net trade sales of CARVYKTI® for the quarter ended December 31, 2024. This achievement highlights the company’s strategic alliance with Janssen Biotech and reflects its strong market positioning in the biotech industry, though the sales figures remain unaudited and stakeholders are advised to exercise caution.
More about Genscript Biotech
Genscript Biotech Corporation, incorporated in the Cayman Islands, operates in the biotechnology industry. It focuses on biotechnological research and development, with a market focus that includes collaborations with other biotech firms such as Legend Biotech Corporation.
YTD Price Performance: -5.51%
Average Trading Volume: 3,780
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.73B
See more insights into 1548 stock on TipRanks’ Stock Analysis page.
